Clinical Trial Update: Modeling DNA Diversity in Cardiovascular Health/Disease

View source ↗

Summary

This entry notes the completion of a clinical trial focused on modeling DNA diversity in cardiovascular health and disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Heart Diseases

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Heart Diseases | Status: COMPLETED